ACTIVE

ONCLINX & Fils

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-65,1 k €-15,0 %over 1 year
Gross margin-15,7 k €-191,6 %over 1 year
Equity856,1 k €-7,1 %over 1 year

Identity

Source · BCE/KBO

ONCLINX & Fils is a Private company with limited liability incorporated in 2006. Its registered office is in Namur.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0884.042.261
Incorporation
28/09/2006
Legal form
Private company with limited liability
Registered office
Rue Martin Lejeune(VD) 37
5020 Namur · Wallonie
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 19 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin-15,7 k €-5,4 k €54,3 k €45 k €12,9 k €
EBITDA-27,1 k €-18,8 k €44,5 k €32,7 k €5,5 k €
Operating result-59,2 k €-50,5 k €12,2 k €954,3 €-22,7 k €
Net result-65,1 k €-56,6 k €5,4 k €-6,9 k €-17,8 k €
Balance sheet
Equity856,1 k €921,2 k €977,9 k €972,4 k €979,3 k €
Total assets1,3 M €1,4 M €1,5 M €1,5 M €1,5 M €
Cash56,2 k €117,5 k €113 k €104,3 k €90,9 k €
Debts483,4 k €512,1 k €525,6 k €553 k €563,6 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

Marie-Hélène Onclinx

Director · since 07 mai 2020

Active

Ended mandates

Marie-Hélène Onclinx

Administrateur · since 15 février 2015

Ended
Marie-Hélène Onclinx

Director · since 15 février 2015

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/06/202606/07/202523/07/202423/08/202313/08/202231/08/2021
General meeting05/06/202606/06/202507/06/202402/06/202303/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202505/06/202624/06/2026FrenchPDF
Micro model31/12/202406/06/202506/07/2025FrenchPDF
Micro model31/12/202307/06/202423/07/2024FrenchPDF
Micro model31/12/202202/06/202323/08/2023FrenchPDF
Micro model31/12/202103/06/202213/08/2022FrenchPDF
Micro model31/12/202004/06/202131/08/2021FrenchPDF
Micro model31/12/201905/06/202008/09/2020FrenchPDF
Micro model31/12/201807/06/201922/10/2019FrenchPDF
Micro model31/12/201706/01/201819/09/2018FrenchPDF
Micro model31/12/201602/06/201714/09/2017FrenchPDF
Abridged model31/12/201503/06/201626/08/2016FrenchPDF
Abridged model31/12/201405/06/201517/11/2015FrenchPDF
Abridged model31/12/201322/08/201427/08/2014FrenchPDF
Abridged model31/12/201207/06/201326/07/2013FrenchPDF
Abridged model31/12/201101/06/201228/08/2012FrenchPDF
Abridged model31/12/201003/06/201105/08/2011FrenchPDF
Abridged model31/12/200904/06/201006/08/2010FrenchPDF
Abridged model31/12/200829/06/200917/08/2009FrenchPDF
Abridged model31/12/200728/06/200829/07/2008FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

Marie-Hélène Onclinx

Director · since 07 mai 2020

Active

Ended mandates

Marie-Hélène Onclinx

Administrateur · since 15 février 2015

Ended
Marie-Hélène Onclinx

Director · since 15 février 2015

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/06/2020
    DENOMINATION - SIEGE SOCIAL - OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF
  • Other28/03/2008
    DIVERS
    PDF
  • Other16/10/2006
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-65,1 k €↓
  2. 2024
    Annual accounts 2024-56,6 k €↓
  3. 2024
    Name changeOnclinx et Fils
  4. 2023
    Annual accounts 20235,4 k €↑
  5. 2022
    Annual accounts 2022-6,9 k €↑
  6. 2021
    Annual accounts 2021-17,8 k €↓
  7. 2019
    Annual accounts 2019-17,1 k €↓
  8. 2019
    Name changeONCLINX & Fils
  9. 2018
    Annual accounts 2018100 k €↓
  10. 2017
    Annual accounts 2017161,6 k €↑
  11. 2016
    Annual accounts 2016136,7 k €↑
  12. 2015
    Annual accounts 2015136 k €↑
  13. 2014
    Annual accounts 2014127,3 k €↑
  14. 2013
    Annual accounts 2013114,1 k €↑
  15. 2012
    Annual accounts 201298,6 k €↓
  16. 2011
    Annual accounts 201198,7 k €↑
  17. 2010
    Annual accounts 201050,8 k €↓
  18. 2009
    Annual accounts 200961,2 k €↑
  19. 2008
    Annual accounts 200818,7 k €↓
  20. 2007
    Annual accounts 200740,3 k €
  21. 2007
    Name changeDocteur ONCLINX
  22. 28/09/2006
    IncorporationPrivate company with limited liability